Unitech Pharmaceuticals, Inc.

Ann Arbor, MI 48108

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $325K
First Award Date 08/01/04
Most Recent Award Date 04/20/07

Key Personnel

Last Name Name Awards Contact
Shaw Jiajiu Shaw 3

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-20
Budget: 04/20/07 - 09/30/07

DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is one of the most common forms of arthritis, a potentially crippling autoimmune disease that affects more than two million Americans. At the present time, DMARD (Disease Modifying Anti- Rheumatic Drug) is an improved class of arthritis drugs over NSAID (Non-Steroidal Anti-Inflammato...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/10/06 - 01/31/07

DESCRIPTION (provided by applicant): Cancer patients treated by radiation usually suffer organ damages in addition to other side effects (hair loss, nausea, and diarrhea). For example, patients with liver cancer, when treated by X-ray, suffer from liver damages and liver function reduction. Unfortunately, there is only one approved drug, Amifost...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/04 - 01/31/05

DESCRIPTION (provided by applicant): Rheumatoid arthritis is a potentially crippling autoimmune disease that affects more than two million Americans. Generally arthritis drugs may be divided into two categories: NSAID (Non-steroidal Anti-Inflammatory Drug) and DMARD (Disease Modifying Anti-Rheumatic Drug). Leflunomide is a DMARD sold as Arava...